we aimed to better define the clinical presentation and the immunologic characteristics of TIN, found in three patients of the cohort.
M AT E R I A L S A N D M E T H O D S
Patients and patient recruitment As the Finnish patient group has a history of willingness to participate in research of their disease, the study recruitment and contact information were collected with the help of the Finnish APECED and Addison Registered Association (APECED ja Addison Ry, http://www.apeced.org). All participating patients were members of the Association, and some of them have participated in other studies from our group [23, 24] . The study was approved by the Medicine Ethical Review Board of Helsinki and Uusimaa Joint Authority (dnro 8/13/03/01/2009), and each participant (or their parents if under 18 years of age) signed an informed consent.
Interview
The survey was performed first using a self-reported questionnaire. The questionnaire explored past or present history of urinary tract infections ( pyelonephritis, cystitis, number of episodes), kidney or urinary tract stones, TIN, renal biopsies, hypertension and uveitis. Besides, male patients were asked specifically if they have previously been diagnosed with a prostatic disease (acute/chronic prostatitis, adenoma or cancer). In order to ensure a good comprehension and to avoid misunderstandings, the questions used both medical terms and an explanatory definition of their meanings. The questionnaire was mailed with an explanatory letter describing the intended research and prepaid return envelopes. No second attempt was performed to contact non-responders.
Clinical records
We have generated a recent clinical database of APECED patients, including demographic data (gender, age, age at APECED diagnosis, age at first onset of symptoms), clinical symptoms, autoimmune endocrine and non-endocrine diseases and occurrence of oral carcinoma or other malignancies, which allows us to compare these findings to the renal and urinary findings. In case of discrepancies or unclear data, we collected information directly from the patients' medical files. In a few cases, the responsible physician was directly contacted by one of us to cross-check the clinical data and the patients' narratives.
Routine laboratory findings
Along with the questionnaire, the patients were asked to send their recent laboratory analysis results (maximum 1 year old), including plasma creatinine, urea nitrogen, plasma cystatin C, proteinuria, low-molecular-weight (LMW) proteinuria, glycosuria, a urinalysis, a urine bacteriology and value for prostate-specific antigen for men. Renal outcome was evaluated by counting the glomerular filtration rate (GFR) using a Cockcroft-Gault formula in adults or bedside Schwartz equation in children. The lack of or incomplete laboratory results were not a criteria of exclusion from the study. Neither baseline hormone levels, nor organ-specific autoantibodies were analysed for this study separately.
Renal biopsies
Renal biopsies had been performed on three patients, and one was available for the review of histologic and immunofluorescence results.
Detection of circulating autoantibodies by enzymelinked immunosorbent assay Patients sera were collected between 2010 and 2012 and stored at −70°C. Antibodies against inflammatory cytokines, frequently present in APECED patients, such as interferon (IFN)-α (α1β, α2β, α4, α5), -γ, -ω, IL-17A, IL-17F and IL-22 were determined by a sandwich enzyme-linked immunosorbent assay (ELISA). Plates were coated with recombinant human INF-α, -γ, -ω, IL-17A, IL-17F, IL-22 (ImmunoTools GmbH, Friesoythe, Germany) were used at 1 mg/mL concentration in phosphate-buffered saline (PBS) with pH 7.0. Sera were added and incubated for 2 h at 22°C. After washing, the bound antibody was detected with antihuman IgG horseradish peroxidase conjugate (Sigma-Aldrich), 1-Step Ultra TMB-ELISA (Thermo Scientific, Rockford, IL) and Stop Solution (2 M, H 2 SO 4 ). Absorbance was read at 450 nm. Sera from 62 age and sex-matched blood donors, provided by the Finnish Red Cross Blood Service, served as controls.
Indirect immunofluorescence assay for specific autoantibodies on rat kidney An indirect immunostaining of formalin-fixed, paraffinembedded rat kidney sections was performed to detect kidneyspecific cross-reactive autoantibodies. Autoantibodies are typically cross-reactive, and rodent tissues can be used for their detection [25] . Tissue sections were deparaffinized, and the endogenous peroxidase activity was quenched with 1 : 10 hydrogen peroxide. Antigen retrieval was performed by heating slides in citrate buffer at pH 6 for 10 min. Blocking was performed with 1% bovine serum albumin. Slides were incubated overnight at +4°C with individual patient sera (1 : 1000 in PBS). As a detection system, VECTASTAIN Elite ABC Kit (Goat IgG) PK-6105 and AEC SK 4200 (Vector Laboratories, Inc., Burlingame, CA) were used. As a control tissue, rat spleen sections, immunostained simultaneously on the same slide, were used. Sera from healthy individuals served as control sera.
R E S U LT S
Of the 33 patients initially contacted, 30 patients with confirmed APECED syndrome volunteered for the study (20 women and 10 men, mean age 40 ± 15.5; response rate 91%). The mean duration of APECED was 37 ± 15.6 years. Fourteen of the patients (46%) had experienced at least one kidney/ urinary tract-related symptom during lifetime (Table 1) . No anatomic abnormality of the urinary tract was reported by any patient. The general characteristics of the patients are summarized in Table 1 . , n = 2). Cystatin C plasma levels were analysed in 15 patients and ranged from 0.83 to 3.55 (mean value 1.37 ± 0.6). Five patients had values >1.4 mg/L.
Abnormalities in renal function
One patient had persistent proteinuria, most likely due to a diabetic nephropathy, since the patient also had symptoms of diabetic retinopathy. Two patients had GFR 40 mL/min/1.73 m 2 , but the cause of the renal dysfunction had not been investigated. Their urinalysis was unremarkable. Lastly, one additional patient had had in the past an episode of acute tubular necrosis related to hypercalcemia during the previous cyclosporine treatment. Cyclosporine was initiated in the context of a corneal transplant, due to severe keratoconjunctivitis. She currently has a normal renal function (GFR >60 mL/ min/1.73 m 2 ).
Tubulo-interstitial nephritis
Among the five patients with diminished GFR, three women (3/30, 10%) had a chronic renal failure related to TIN, confirmed by a kidney biopsy. They were all carriers of the Finn major AIRE mutation (R257X×2). Patient 1 had undergone a renal transplantation. She was diagnosed at the age of 20 and was transplanted at the age of 33, 15 years before this study, with no rejection. She is currently under cyclosporine treatment (GFR 55 mL/min/1.73 m 2 ). Patient 2, aged 27, was diagnosed with TIN with nephrocalcinosis at the age of 16. Renal involvement was suspected on low potassium and hypertension. Urinalysis disclosed a sterile pyuria without proteinuria or glycosuria. Urinary LMW β2-microglobulin was elevated (1.05 mg/L, N < 0.35). Aldosterone and renin plasma levels were diminished. Renal biopsies confirmed a diagnosis of TIN. Her creatinine plasma levels were increasing progressively within a few years. No immunosuppressive treatment was initiated, and the patient is currently on haemodialysis. Patient 3, a young girl aged 12, was diagnosed as having TIN at the age of 9 and is currently followed up because of progressive worsening of kidney function (plasma creatinine 143 µmol/L; GFR 53 mL/min/1.73 m 2 ) and renal tubular acidosis (RTA) type 1. Supportive treatment by sodium bicarbonate was started when the kidney involvement was observed. Mycophenolate mofetil (MMF) was not efficient to control the disease. Chimeric monoclonal anti-CD20 antibody (rituximab) was attempted but did not show any efficacy as after 10 months of follow-up her plasma creatinine levels remain elevated.
None of these three patients had any prior history of other renal diseases prior to the discovery of TIN. They did not have uveitis or other autoimmune disease that could be related to TIN, such as systemic lupus, Sjögren's syndrome or sarcoidosis).
Renal biopsies had been performed for all three patients with suspicion of TIN. Biopsies could not be traced in one patient, and a second sample was too small for reinterpretation. Therefore, only one biopsy sample was available for this study (Patient 3). The kidney cortex was mostly normal with a slight interstitial lymphocytic inflammation affecting 10% of the parenchyma. However, the changes were more severe in the juxtamedullary cortex. Moderate inflammation, tubular atrophy and some dilated tubuli with proteinaceous periodic acid-Schiff-positive material as well as slight fibrosis were found ( Figure 1A-C) . Glomeruli were normal apart from slight mesangial cell proliferation. Methenamine-silver stain showed normal glomerular basement membranes. A distinct but focal inflammatory lymphocytic infiltrate comprising mainly T cells (CD3+ cells 90%, CD4+ cells 55% and CD8+ lymphocytes 35%; Figure 1D-F) . CD20-positive lymphocytes were rare (10%) (Figure 1G ), and eosinophils were absent. Among these lymphatic infiltrates, a few cells with a cytotoxic activity were seen: 3-5% of the cells were TIA-1-positive and 2-3% granzyme B-positive ( Figure 1H and I) . Tubular calcification was variable. Tubular atrophy and interstitial fibrosis were seen (Figure 1 
Urinary tract infections
Past history of bacterial cystitis was reported by 12 women. Two of them had a past history of cystitis during childhood. The frequency of self-reported infection varied from only 1 to >10 life-time episodes. Pyelonephritis was reported in two cases with no sequelae (2/30, 6%; 2/12, 16%).
Other findings Two patients had a history of RTA type 1. One of these patients had a past history of RTA type 1 that resolved and has nowadays a normal renal function while in the other case RTA 1 is related to APECED TIN. Two patients had a nephrocalcinosis, including one with TIN.
Kidney stones were mentioned by two patients. One patient had a typical symptomatic renal colic episode at the age of 8 with lower back and abdominal pain with haematuria related to uric acid lithiasis. No male patient reported prostatic diseases. Hypertension was found in 11 patients (11/29), including the patient with TIN under cyclosporine therapy for renal transplantation.
Kidney-specific immunofluorescence findings
The sera of 9/30 (30%) patients disclosed a positive immunostaining in the area of the distal part of the nephron, consisting of the distal tubules, Henle's loop and collecting tubes with various intensity of reactivity, while no staining of the proximal tubular epithelium was seen (Figure 3) . Two of the three patients with TIN had a strong staining while the third patient's staining intensity was less. In the rest of the patients, we did not find a concordance between a positive tubular immunostaining and either low GFR <60 mL/min or elevated levels of cystatin C. No staining was observed on the rat spleen sample on the slides next to the kidney. Similarly, human control sera did not disclose any staining in the tubules.
Circulating anticytokine autoantibodies
We looked for eventual correlation of the patients' circulating autoantibodies against IFNα, IFNω, IL22 and IL17F (Table 1) , the antitubular autoantibodies and TIN. However, we failed to find any correlation between TIN and occurrence of antibodies.
D I S C U S S I O N
We report here, for the first time in a relatively large patient cohort, the renal and urinary manifestations of APECED and the frequent (30%) occurrence of autoantibodies against the renal tubular structures. Forty-six per cent of the patients had at least one episode of kidney or urinary tract-related disease, and biopsy proven TIN was diagnosed in 3/30 (10%) of the patients. TIN is a rare manifestation that can lead to permanent renal dysfunction, haemodialysis and renal transplantation. Our result on TIN prevalence is in concordance with the findings by Perheentupa [1] while TIN with renal dysfunction is rarely reported in the literature [20] [21] [22] .
TIN is a significant cause of acute renal insufficiency in adults and children. It is characterized by infiltration of inflammatory cells, mainly lymphocytes, into the renal interstitium and tubular wall [22] . Clinical symptoms are known to be non-specific (fever, headache, fatigue, anorexia) [26] , but they are even less specific in APECED patients, who typically suffer from several endocrinopathies, as adrenal failure or hypothyroidism, that could be responsible per se for similar symptoms. Unexplained fever is also a distinct feature of APECED, especially in children [1] . Therefore, TIN is usually suspected on the basis of elevated serum creatinine, increased erythrocyte sedimentation rate, abnormal urinalysis, LMW proteinuria and glycosuria [26] . A striking feature in APECED is that the only clinical manifestation of TIN maybe decreased renal function with no anomalies upon urinalysis [17] . In one of our patients, only pyuria and urinary excretion of LMW proteins were found whereas in two patients, glycosuria was totally absent. This observation may be fortuitous, but it could also be a clue to consider APECED-related TIN as a distinct TIN process.
Acute or chronic TIN can be caused by a wide number of diseases, such as drugs, autoimmune diseases, obstruction, lithiasis or infections. As mentioned, APECED predisposes to a number of organ-specific autoimmune diseases, but systemic lupus erythematosus and pauci-immune vasculitis have never been reported, to our knowledge. Also Sjögren's syndrome is exceedingly rare. None in our patient cohort had antinuclear antibodies at significant titres [24] . The high incidence of uveitis among children with TIN (TINU; 46%) has been emphasized recently [26] . However, keratoconjunctivitis is the main ophthalmologic manifestation of APECED while uveitis is quite rare [27] . None of our patients with confirmed TIN displayed ocular manifestations. Although uveitis can be asymptomatic during TIN [26] , APECED patients are usually closely monitored for eye symptoms. TINU is, therefore, unlikely in APECED.
Kidney biopsy is mandatory to confirm the diagnosis of TIN and can help distinguish the different causes [28] . Patients with APECED suffer from chronic inflammation of internal organs due to infiltrative autoreactive T lymphocytes. During APECED-related TIN, inflammation appears to be rather patchy, comprising of lymphocytes with scattered plasma cells [20] . Tubular atrophy and fibrosis may already be present while granuloma, vasculitis and amyloidosis are absent. Two of our patients with TIN displayed renal deposits of immunoglobulins in the tubules, the mesangium and some sclerosed glomeruli. Hannigan et al. [20] observed focal granular/linear IgG and C3 staining of tubular basement membranes while Al-Owain et al. [22] found mesangial depositions of C3 and C1q and IgM in the glomeruli in APECED-associated TIN.
The target renal antigens in APECED-associated TIN are not known, even though antibodies against the distal part of the nephron, consisting of the distal tubules, Henle's loop and collecting tubes are found in our series. The mechanisms that elicit such an antibody response, as well as the clinical significance of the autoantibodies, remain undefined. Like in other organ-specific autoimmune disorders associated with APECED, the tissue destruction is understood to be primarily mediated by T cells, and autoantibodies may only have a limited role in the pathogenesis. APECED patients have a significantly increased frequency of highly differentiated CD8+ effector cells combined with a deficiency in the regulatory CD25+ CD4+ T cells [3] . In our series, the three patients with TIN did show an antitubular antibody response but six others also had similar autoantibodies without TIN or renal dysfunction. The presence of autoantibodies without manifest clinical disease is quite common, if not a rule, in many autoimmune diseases so that only a fraction develops an overt clinical disease [29] . A combination of a risk human leucocyte antigens haplotype and probably environmental factors may contribute. It is thus possible that our patients with antitubular antibodies but without overt TIN have an ongoing subclinical process. Only a long-term follow-up will reveal whether the antibodies could preclude the development of TIN. However, the hypothesis of a T-cell-mediated reaction is strengthened by the history of Patients 1 and 3. Patient 1 has had a kidney transplant for 18 years without signs of rejection. She had used cyclosporine, a T-cell inhibitor, and yet displayed a strong antibody reactivity against the tubules. Rituximab, targeting antibody-producing B cells, was tried in Patient 3, with a recent onset kidney disease, although CD20-positive cells were rather rare in the inflammatory infiltrate. In her case, tubular immunostaining was still observed with a serum sample of 3 months after rituximab infusion, and at 10 months of follow-up, her creatinine levels remained high.
During APECED, organ-specific autoantibodies are often directed against intracellular enzymes. They are usually considered not to have a pathological significance, but rather reflect the ongoing T-cell activity at the target tissue [3] . However, in the beginning of the 1980s, Gaarder and Heier isolated a human autoantibody against renal collecting duct cells in a series of patients with various autoimmune endocrine disorders, thyroid disorders and gastric atrophy especially [30] . Besides, they also hypothesized a possible association between collecting duct cells antibodies and the occurrence of distal RTA (type 1) based on a few patients [30] . Our series is too limited to draw any conclusion on a potential association between endocrine disorders and the distal nephron autoantibodies. We can simply state that 50% (1/2) of the patients with pernicious anaemia, 40% (2/5) with diabetes type 1, 30% (7/23) with Addison's disease and with hypothyroidism (3/10) have such circulating autoantibodies. Interestingly though, in our series, one of our two patients with a history of RTA type 1 displayed those autoantibodies. In the other patient, the tubular acidosis resolved several years before the serum was collected and one can speculate that the circulating autoantibody may have been cleared since. An alternative hypothesis is that the tissue-specific autoantibodies develop after a renal tissue injury, caused by an autoimmune reaction, infection (e.g. pyelonephritis) or trauma (lithiasis).
Similarly, patients operated on gastric ulcer may develop an antibody response against gastric parietal cells [31] , and patients with chronic viral hepatitis may develop chronic active hepatitis with tissue autoantibodies [32] . A third explanation is that the autoantibodies represent an epiphenomenon reflecting the defect in negative thymic selection due to AIRE deficiency, as patients with APECED develop a myriad of antiorgan-specific antibodies.
Lastly, anticytokine autoantibodies, such as anti-IL17, anti-IL-22 and INFα, are common in APECED and they have been shown to have a neutralizing effect [3] . The question whether and how all these antibodies interfere with an autoimmune organ attack, remains open.
The therapeutic strategy of TIN is not clearly established, but early initiation of immunosuppressive therapy could theoretically decrease fibrosis formation in the kidney [28] . However, mycophenolate mofetil was not efficient in Patient 3, whereas Ulinski et al. [21] showed beneficial effects of this treatment. The beneficial effect of MMF on APECED activity can be explained by two potential mechanisms: reduction of putative anti-T helper cell antibodies and reduction of T suppressor cells, resulting in an increase in T helper to T suppressor cell ratio. Rituximab was also disappointing in our case, despite positive results in other rare conditions associated with APECED [33] .
CO N C L U S I O N
TIN is a rare complication of APECED that can lead to chronic renal failure. The diagnosis of TIN should be confirmed by a renal biopsy, and demonstration of autoantibodies against the renal distal tubules can be of additional diagnostic aid. Our observation in one paediatric case failed to show an efficacy of immunosuppressive therapy to slow down or stop the renal autoimmune attack.
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